{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:36:46Z","timestamp":1782038206307,"version":"3.54.5"},"reference-count":16,"publisher":"Norwegian Medical Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.23.0782","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T10:15:13Z","timestamp":1710152113000},"source":"Crossref","is-referenced-by-count":1,"title":["Treating status epilepticus in adults"],"prefix":"10.4045","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2057-694X","authenticated-orcid":false,"given":"Kjell","family":"Heuser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Samsonsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line B\u00e9dos","family":"Ulvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil Berg","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti Nesheim","family":"Power","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyri","family":"Veiby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Molteberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernt","family":"Engelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Taub\u00f8ll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Trinka\u00a0E, Cock\u00a0H, Hesdorffer\u00a0D et al. A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56: 1515\u201323. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26336950&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fepi.13121","DOI":"10.1111\/epi.13121"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Trinka\u00a0E, Leitinger\u00a0M. Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus. Continuum (Minneap Minn) 2022; 28: 559\u2013602. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35393970&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212%2FCON.0000000000001103","DOI":"10.1212\/CON.0000000000001103"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Betjemann\u00a0JP, Lowenstein\u00a0DH. Status epilepticus in adults. Lancet Neurol 2015; 14: 615\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25908090&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1474-4422(15)00042-3","DOI":"10.1016\/S1474-4422(15)00042-3"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Ulvin\u00a0LB, Heuser\u00a0K, Olsen\u00a0KB et al. Factors associated with refractoriness and outcome in an adult status epilepticus cohort. Seizure 2018; 61: 111\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30125862&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.seizure.2018.07.020","DOI":"10.1016\/j.seizure.2018.07.020"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Roberg\u00a0LE, Monsson\u00a0O, Kristensen\u00a0SB et al. Prediction of Long-term Survival After Status Epilepticus Using the ACD Score. JAMA Neurol 2022; 79: 604\u201313. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35404392&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjamaneurol.2022.0609","DOI":"10.1001\/jamaneurol.2022.0609"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Heuser K, Olsen KB, Ulvin LB et al. Modern Treatment of Status Epilepticus in Adults. I: Czuczwar SJ, red. Epilepsy. Brisbane: Exon Publications, 2022.","DOI":"10.36255\/exon-publications-epilepsy-status-epilepticus"},{"key":"ref=7","unstructured":"Chamberlain\u00a0JM, Kapur\u00a0J, Shinnar\u00a0S et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet 2020; 395: 1217\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32203691&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(20)30611-5"},{"key":"ref=8","unstructured":"NNF\/NevroNEL https:\/\/nevrologi.legehandboka.no Lest 4.2.2024."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Naylor\u00a0DE, Liu\u00a0H, Wasterlain\u00a0CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005; 25: 7724\u201333. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16120773&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1523%2FJNEUROSCI.4944-04.2005","DOI":"10.1523\/JNEUROSCI.4944-04.2005"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Naylor\u00a0DE, Liu\u00a0H, Niquet\u00a0J et al. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol Dis 2013; 54: 225\u201338. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23313318&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.nbd.2012.12.015","DOI":"10.1016\/j.nbd.2012.12.015"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Horn\u00a0MA, Hov\u00a0MR, Heuser\u00a0K et al. Tid til kontroll som kvalitetsm\u00e5l ved h\u00e5ndtering av kramper. Tidsskr Nor Legeforen 2023; 143. doi: 10.4045\/tidsskr.23.0230. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37341400&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.23.0230","DOI":"10.4045\/tidsskr.23.0230"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Silbergleit\u00a0R, Durkalski\u00a0V, Lowenstein\u00a0D et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591\u2013600. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22335736&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1107494","DOI":"10.1056\/NEJMoa1107494"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Habhab\u00a0SF, Ulvin\u00a0LB, Taub\u00f8ll\u00a0E et al. Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort. Epilepsy Behav 2020; 111: 107193. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32759060&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.yebeh.2020.107193","DOI":"10.1016\/j.yebeh.2020.107193"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Rossetti\u00a0AO, Lowenstein\u00a0DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011; 10: 922\u201330. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21939901&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1474-4422(11)70187-9","DOI":"10.1016\/S1474-4422(11)70187-9"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Caranzano\u00a0L, Novy\u00a0J, Rossetti\u00a0AO. Ketamine in adult super-refractory status epilepticus: Efficacy analysis on a prospective registry. Acta Neurol Scand 2022; 145: 737\u201342. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35274736&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fane.13610","DOI":"10.1111\/ane.13610"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Tan\u00a0TH, Perucca\u00a0P, O'Brien\u00a0TJ et al. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease. Epilepsia 2021; 62: 303\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33316111&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fepi.16788","DOI":"10.1111\/epi.16788"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Behandling av status epilepticus hos voksne"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:01:52Z","timestamp":1781686912000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2024\/03\/klinisk-oversikt\/behandling-av-status-epilepticus-hos-voksne"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,19]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.23.0782","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}